TNFRSF4 Antikörper (AA 228-277)
-
- Target Alle TNFRSF4 Antikörper anzeigen
- TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
-
Bindungsspezifität
- AA 228-277
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TNFRSF4 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunofluorescence (IF)
- Spezifität
- TNR4 Antibody detects endogenous levels of total TNR4 protein.
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide from human TNR4 (aa228-277).
Type of Immunogen: Synthetic peptide - Isotyp
- IgG
- Top Product
- Discover our top product TNFRSF4 Primärantikörper
-
-
- Applikationshinweise
- Approved: IF (1:100 - 1:500), Peptide-ELISA (1:10000)
- Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C.
-
- Target
- TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
- Andere Bezeichnung
- TNFRSF4 / CD134 / OX40 (TNFRSF4 Produkte)
- Synonyme
- TNFRSF4 antikoerper, ACT35 antikoerper, CD134 antikoerper, Ly-70 antikoerper, Ox40 antikoerper, TXGP1L antikoerper, Txgp1 antikoerper, OX40 antikoerper, TNF receptor superfamily member 4 antikoerper, tumor necrosis factor receptor superfamily, member 4 antikoerper, TNFRSF4 antikoerper, Tnfrsf4 antikoerper
- Hintergrund
-
Name/Gene ID: TNFRSF4
Family: TNF Receptor
Synonyms: TNFRSF4, ACT35 antigen, ATC35 antigen, CD134, ACT35, OX40, OX40 antigen, OX40L receptor, OX40 homologue, CD134 antigen, OX40 cell surface antigen, TXGP1L - Gen-ID
- 7293
- UniProt
- P43489
- Pathways
- Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
-